# Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability

> **NCT04821856** · PHASE2 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 132 (actual)

## Conditions studied

- Intellectual Disability
- Child Behavior Problem

## Interventions

- **DRUG:** Cannabidiol Oil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04821856
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-11
- **Primary completion:** 2025-07-09
- **Final completion:** 2025-08-19
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821856, "Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04821856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*